- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00607126
Locomotor Training in Persons With Multiple Sclerosis
Robotic Locomotor Training in Persons With Multiple Sclerosis
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
In this study, subjects with confirmed diagnosis of Multiple Sclerosis were randomized into one of two treatment arms. Subjects in the Lokomat arm trained on the Lokomat with a supervising physical therapist for 20-30 minutes/session 3 times/week. The Lokomat is a robotic exoskeleton which enables the subject to step on a moving treadmill. Subjects were suspended in a harness while in the Lokomat with full to partial body weight support as needed. After the training in the Lokomat, they practiced overground walking for 10 minutes.
The other treatment arm had subjects engage in resistance training with weights and resistance elastic bands matched to the Lokomat group for intensity, duration and frequency. they did not practice overground walking.
Primary outcome measure was speed to accomplish 25' timed walk.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 2
- Fas 1
Kontakter och platser
Studieorter
-
-
California
-
Los Angeles, California, Förenta staterna, 90095
- UCLA
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Persons with Secondary progressive or Primary Progressive Multiple Sclerosis who are ambulatory with difficulty and /or assistive device
Exclusion Criteria:
- Ataxia
- Unable to ambulate
- Within 3 months of exacerbation
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: 1
locomotor training using body weight support on a treadmill, using robotic device to provide locomotor training.
Locomotor training will be done using the Lokomat device.
the patient is suspended over a treadmill while their legs are in the Lokomat, which moves the legs on the treadmill.
|
locomotor training using body weight support on a treadmill
|
Aktiv komparator: 2
resistive training using weights and therabands
|
resistive training using theraband and/or weights
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Walking Speed as Assessed by 25' Timed Walk
Tidsram: at beginning,mid point, end and 12 weeks after intervention
|
This is the time needed for participant to walk 25 feet.
Participant walks on a level surface.
the walk from start to finish is timed with a stop watch three measures are done and the average value is entered.
|
at beginning,mid point, end and 12 weeks after intervention
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Distance
Tidsram: baseline, mid point, end and 12 weeks after training
|
distance assessed by 6 minute walk test
|
baseline, mid point, end and 12 weeks after training
|
Fatigue
Tidsram: baseline, mid, completetion, 3 months post
|
fatigue assessed by modified fatigue impact scale.
This is a 21 item questionnaire which has a range from 0-84.
Higher scores indicate more impact of fatigue on physical and cognitive functioning.
|
baseline, mid, completetion, 3 months post
|
PASAT
Tidsram: baseline, mid, completion, 3 months post training
|
Cognitive measure of attention and information processing speed.
Score goes from 0-60 with higher number indicating better performance.
Scores are expressed as mean chamge rfom baseline; negative numbers indicate worse performance
|
baseline, mid, completion, 3 months post training
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Barbara S Giesser, MD, University of California, Los Angeles
Publikationer och användbara länkar
Allmänna publikationer
- Giesser B, Beres-Jones J, Budovitch A, Herlihy E, Harkema S. Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. Mult Scler. 2007 Mar;13(2):224-31. doi: 10.1177/1352458506070663.
- Giesser B, Herlihy E, Plummer D'Amato P et al. Randomized controlled trial of robotic locomotor training in persons with MS. Multiple Sclerosis Journal 17S481 ( 2011)
- Giesser B, Herlihy, E, PlummerD'Amato P, et al. Locomotor training may improve cognitive performance in persons with MS. Neurology 72 ( Suppl.3) A 405 (2009)
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 06-04-064-02
- RG3724-A-4 (Annan identifierare: National MS Society)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Multipel skleros
-
Centre Hospitalier Universitaire de NīmesAvslutadMonckeberg Medial Calcific SclerosisFrankrike
-
Assistance Publique - Hôpitaux de ParisOkändArteriosclerosis Obliterans | Diabetiska vaskulära sjukdomar | Monckeberg Medial Calcific SclerosisFrankrike
-
City of Hope Medical CenterNational Cancer Institute (NCI)Aktiv, inte rekryterandeKlassiskt Hodgkin lymfom | Lymfocytrikt klassiskt Hodgkin-lymfom | Ann Arbor stadium IB Hodgkin lymfom | Ann Arbor stadium II Hodgkin lymfom | Ann Arbor stadium IIA Hodgkin lymfom | Ann Arbor stadium IIB Hodgkin lymfom | Ann Arbor stadium I Hodgkin lymfom | Ann Arbor Steg I blandad cellularitet Klassiskt... och andra villkorFörenta staterna